Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-01-03 @ 10:20 PM
Study NCT ID:
NCT03608358
Status:
TERMINATED
Last Update Posted:
2022-05-31
First Post:
2018-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-27
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-04
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-11
First Submit QC Date:
None
Study First Post Date:
2018-07-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-25
Last Update Post Date:
2022-05-31
Last Update Post Date Type:
ACTUAL